Archive
09 Jul Policy Position of the South African Health Products Regulatory Authority on Enabling Local Manufacturing
Posted at 15:52h
in
During the last decade, promoting sustainable access to quality and affordable medicines has been of significant concern to African leaders. More recently the opportunity to promote local, regional and continental production of the medicines needed is considered as part of the overall health systems strengthening...
10 Apr Communication Regarding the Development of a Policy Relating to the Issuing of Licences in Terms of Section 22c(1)(B) of the Medicines and Related Substances Act, 101 of 1965, in Accordance With Broad-based Black Economic Empowerment Principles
Posted at 15:39h
in
The South African Health Products Regulatory Authority (SAHPRA) is a statutory body established in terms of Section 2 of the Medicines and Related Substances Act, 101 of 1965, as amended. The objects of the Authority are to provide for the monitoring, evaluation, regulation, investigation, inspection,...
03 Apr SAHPRA Strategic Plan 2025 and 2026 – 2029 and 2030
Posted at 11:04h
in
As the South African Health Products Regulatory Authority (SAHPRA) embarks on the journey outlined in our Strategic Plan for 2025–2030, it is imperative to reaffirm our commitment to ensuring access to safe, effective, and high-quality health products. Guided by our reinforced vision— an agile and...
03 Apr SAHPRA Annual Performance Plan 2025– 2026
Posted at 10:28h
in
As the South African Health Products Regulatory Authority (SAHPRA) embarks on the journey outlined in our Annual Performance Plan for 2025–2026, it is imperative to reaffirm our commitment to ensuring access to safe, effective, and high-quality health products. Guided by our reinforced vision— An agile...
25 Feb An Extension to the Exemption of medical Devices and In-Vitro Diagnostics (IVDs) from the provisions of Section 18A and Section 18B of the Medicines and Related substance , 1965(ACT No 101 of 1965 )
Posted at 11:38h
in
Government Gazette for Class A medical devices and in vitro diagnostic exemption from section of Section 22C(1) of the medicines and related substance Act 101 of 1965....
17 Sep Communication to Industry – Policy Position of SAHPRA on Enabling Local Manufacture
Posted at 20:26h
in
Policy Position of SAHPRA on Enabling Local Manufacture
SAHPRA as an organ of state and a public entity is required to align itself with the national imperatives to support the national response in public health emergencies through supporting local manufacturers of health products.
...
30 Aug Annual Report (2023/2024)
Posted at 14:09h
in
SAHPRA's Annual Report allows for transparency, accountability, as well as a comprehensive view of the entity’s performance and strategic direction....